The interaction of methyl mercury with erythrocytes

Methylmercury's chemistry: From the environment to the mammalian brain

Methylmercury is a neurotoxicant that is found in fish and rice. MeHg's toxicity is mediated by blockage of -SH and -SeH groups of proteins. However, the identification of MeHg's targets is elusive. Here we focus on the chemistry of MeHg in the abiotic and biotic environment. The toxicological chemistry of MeHg is complex in metazoans, but at the atomic level it can be explained by exchange reactions of MeHg bound to -S(e)H with another free -S(e)H group (R¹S(e)-HgMe + R²-S(e)H ↔ R¹S(e)H + R²-S(e)-HgMe). This reaction was first studied by professor Rabenstein and here it is referred as the "Rabenstein's Reaction". The absorption, distribution, and excretion of MeHg in the environment and in the body of animals will be dictated by Rabenstein's reactions. The affinity of MeHg by thiol and selenol groups and the exchange of MeHg by Rabenstein's Reaction (which is a diffusion controlled reaction) dictates MeHg's neurotoxicity. However, it is important to emphasize that the MeHg exchange reaction velocity with different types of thiol- and selenol-containing proteins will also depend on protein-specific structural and thermodynamical factors. New experimental approaches and detailed studies about the Rabenstein's reaction between MeHg with low molecular mass thiol (LMM-SH) molecules (cysteine, GSH, acetyl-CoA, lipoate, homocysteine) with abundant high molecular mass thiol (HMM-SH) molecules (albumin, hemoglobin) and HMM-SeH (GPxs, Selenoprotein P, TrxR1-3) are needed. The study of MeHg migration from -S(e)-Hg- bonds to free -S(e)H groups (Rabenstein's Reaction) in pure chemical systems and neural cells (with special emphasis to the LMM-SH and HMM-S(e)H molecules cited above) will be critical to developing realistic constants to be used in silico models that will predict the distribution of MeHg in humans.

Probing bioinorganic chemistry processes in the bloodstream to gain new insights into the origin of human diseases

In the context of elucidating the origin of human diseases, past poisoning epidemics have revealed that exceedingly small doses of inorganic environmental pollutants can result in dramatic effects on human health. Today, numerous organic and inorganic pollutants have been quantified in human blood, but the interpretation of these concentrations remains--from a public health point of view--problematic. Conversely, the biomolecular origin for several grievous human diseases is essentially unknown. Taken together and viewed in the context of recent bioinorganic research findings, the established human blood concentrations of toxic metals and metalloids may be functionally connected with the etiology of specific human diseases. To unravel the underlying biomolecular mechanisms, and taking into account the basic flow of dietary matter through mammalian organisms, a better understanding of the bioinorganic chemistry of toxic metals and metalloid compounds in the bloodstream is emerging as a promising avenue for future research. To this end, the concerted application of modern proteomic methodologies, synchrotron-based X-ray absorption spectroscopy and established spectroscopic techniques will contribute to better define the role that blood-based bioinorganic chemistry-related processes play in the origin of human diseases. The application of this and other modern proteomic methodologies could contribute to a better understanding of the role that blood-based bioinorganic chemistry-related processes play in the origin and etiology of human diseases.

Inhibitory effect of selenium on enzymes involved in heme biosynthetic pathway in chick embryos

Effect of different concentrations of selenium (Se) on heme biosynthesis was studied at different developmental stages of chick embryo. The first rate limiting enzyme ALA-synthase (ALA-S; E.C.2.3-1.37) activity was enhanced by selenium, while hepatic and blood ALA-dehydratase activity (ALA-d; E.C.3.2.1.24) was decreased. Hepatic and blood free-sulfhydryl (-SH) group contents were significantly decreased by Se. Further, hepatic aminolevulinic acid (ALA) and total blood porphyrin levels were enhanced and hepatic heme levels were depleted by selenium exposure. Heme biosynthesis was maximally inhibited in the E4 (4th day injected embryos) when compared to later periods.

In vitro studies on methyl mercury distribution in human blood

Studies comparing the methyl mercury (mHg) content of maternal and newborn blood have shown increased levels in the newborn. This has been attributed to facilitated transplacental diffusion because of high fetal hematocrit (Hct). This study shows the converse, that the diffusion of mHg diminishes progressively with increasing Hct. The diffusion of m203Hg across a Millipore membrane (0.45 microns) separating compartments A and B of a diffusion cell was studied. When both compartments contained saline or plasma alone, equilibration from A to B occurred in 5 h. Introduction of human red blood cells (RBC) in saline (Hct 20%) into B resulted in a twofold increase in diffusion of mHg when compared to saline alone. Increasing Hct in saline in compartment B resulted in a progressive decrease in diffusion (r = -0.95, P less than 0.001). The presence of RBC in plasma (Hct 20%) in B resulted in a 70% decrease in diffusion; with increasing Hct, diffusion was further reduced (r = -0.95, P less than 0.001). Direct addition of mHg to RBC in saline resulted in 98% RBC uptake. Increasing concentrations of plasma (at a constant Hct) resulted in a progressive decrease in RBC uptake. In undiluted plasma at Hct 14%, RBC uptake of mHg was 35%. Plasma electrophoresis showed that much of the mHg was associated with a high-molecular-weight lipoprotein fraction. Plasma components appear to be important in the distribution of mHg in blood, and may be a factor in the relatively higher blood levels in the fetus.

Hereditary analysis of the strain difference of methylmercury distribution in mice

Hereditary analyses of strain differences in the distribution of methylmercury (MeHg) were carried out with various strains of mice. First, dose-response relationships were examined with 6-week-old male mice of four strains at seven dose levels from 0.25 to 6.0 mg CH3HgCl/kg. Significant strain differences in dose-response were found for both blood and brain. Second, the frequency distribution of blood mercury concentration was examined with two inbred strains, C3H and C57BL, their hybrid (F1), F2 generation, and back-cross mice. The F1 generation showed an intermediate value between their parents, and characteristic hereditary segregations were found in the frequency of blood mercury concentration in F2 and back-cross mice. Third, the relationship between blood mercury concentration and the molecular structure of mouse hemoglobins (Hb) was examined with 14 strains of inbred mice and a single wild mouse strain. Five strains with Hb-beta d and one strain with Hb-beta p showed blood mercury concentrations twice as high as the other Hb-beta strains. Through these experiments, Hb structure, especially the number and position of cysteinyl residue in the molecule, was found to play a primary role in binding with MeHg and in determining blood mercury concentration.

A study on the biochemical and biological behavior of methylmercury

The biochemical and biological behavior of methylmercury (MeHg) was investigated by measurement of MeHg release rate from erythrocytes (RBC) of selected animal strains and species, by measurement of the intracellular distribution of MeHg in RBC, and by measurement of the binding affinity of hemoglobin (Hb) for MeHg. Methylmercury chloride was used throughout the experiments. Significant strain and species differences were found in the release rate of MeHg from RBC of mice, rats, and man and in the distribution of MeHg in RBC. Significant correlations were found between the above two indexes and the brain/blood ratio of mercury concentration 24 hr after MeHg injection, ip. The affinity of Hb for MeHg was examined by ultrafiltration techniques and Scatchard plots. There were Hbs with only one type of binding site and others with two types of binding sites. Both sites were considered to be cysteinyl residues. Primary sites involved cysteinyl residues oriented externally at the outside of the alpha 1 beta 1 contact junction and cysteinyl residues in the junction, while secondary sites involved only cysteinyl residues in the junction.

H nmr study of the effectiveness of various thiols for removal of methylmercury from hemolyzed erythrocytes

The effectiveness of eight thiol ligands for removing methylmercury (CH3Hg(II)) from its glutathione and hemoglobin complexes in hemolyzed erythrocytes has been studied by 1H nuclear magnetic resonance spectroscopy. These complexes are the predominant methylmercury species in human erythrocytes. The effectiveness was determined from the exchange-averaged chemical shift of the resonance for the proton on the alpha-carbon of the cysteinyl residue and from the intensity of the resonance for the methylene protons of the glycine residue of reduced glutathione (GSH), both of which provide a measure of the amount of glutathione in the CH3Hg(II)-complexed form. The thiol ligands were found to release GSH from its CH3Hg(II) complex in the order 2, 3-dimercaptosuccinic acid greater than mercaptosuccinic acid greater than cysteine greater than mercaptoacetic acid greater than D-penicillamine greater than 2,3-dimercaptopropanesulfonic acid greater than N-acetyl-D,L-penicillamine greater than D,L-homocysteine.

Interactions of aflatoxin B1 and blood components of various species in vitro: interconversion of aflatoxin B1 and aflatoxicol in the blood

The fate of aflatoxin B1 (AFB1) in the blood of various species of animals was studied in vitro. Examination of the distribution of radioactivity in blood incubated with [14C]AFB1 at 37 degrees C showed that high levels of radioactivity were associated with blood cells. The radioactivity was readily removed from the blood cells by washing with fresh plasma, indicating loose binding of AFB1 to blood cells. Most of the radioactivity in plasma was bound to protein. These results suggest that a large part of the AFB1 in blood in vivo may be carried not only by the plasma proteins but also by the blood cells. When chloroform extracts of plasma of [14C]AFB1-treated mouse, rat, duckling, and hamster blood were developed by thin-layer chromatography, high levels of radioactivity were found in both the AFB1 region and the aflatoxicol (AFL) region. Incubation of blood with nonradioactive AFB1 and AFL showed marked interconversion of AFB1 and AFL in the blood of rats, hamsters, mice, and Mongolian gerbils, but not in the blood of guinea pigs, rhesus monkeys, squirrel monkeys, or humans. Interconversion occurred in red blood cell suspensions but not in plasma, indicating that the red blood cells are responsible for AFB1-AFL interconversion in the blood.

Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. II. Effects on metalloproteins

The implications of the carrier mediated uptake of 2,3-dimercaptopropane-1-sulfonate (DMPS) (D.B. Wildenauer et al., Chem.-Biol. Interact., 42 (1982) 165) on cytoplasmic components of human red blood cells have been investigated in vitro. The water-soluble chelating agent caused a mobilization of metals (zinc and copper) from metalloproteins which resulted in a permeation of the membrane. Furthermore, a cytoplasmic protein was found to be attached to the membrane after DMPS treatment of red blood cells. The protein was isolated and identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), amino acid analysis and finger-printing as carbonic anhydrase. The enzyme could be solubilized from the membrane by addition of beta-mercaptoethanol, suggesting an involvement of sulfhydryl-groups. In a reconstitution experiment, DMPS-treated human carbonic anhydrase could be attached to inside-out vesicles which were prepared from human erythrocytes. In contrast, bovine carbonic anhydrase, which is known to lack sulfhydryl-groups, failed to bind to the same vesicles. Moreover, attachment of carbonic anhydrase to the membrane did not occur when intact bovine erythrocytes were treated with DMPS. It is suggested that zinc-depletion of carbonic anhydrase causes the liberation of a sulfhydryl-group of the enzyme. This is followed by a disulfide formation with a component of the membrane which results in the observed membrane attachment.

Evaluation of methyl mercury chelating agents using red blood cells and isolated hepatocytes

The relative efficacy of thiol-containing mercurial scavengers was assayed by using cellular suspensions of erythrocytes or isolated hepatocytes. The blood cells incubated in a buffer (pH 7.4) containing 1 mM glucose (10% hematocrit) were exposed to 5 microM methyl mercuric chloride. In the absence of extracellular thiols the red blood cells took up more than 90% of methyl mercury from the surrounding medium during 5--10 min. This uptake was almost completely inhibited by dimercaptosuccinic acid (DMSA) (1 mM) and the same chelant could rapidly remove 80% of the mercury from 'pre-loaded' erythrocytes. Hepatocytes prepared according to the method of Seglen [11] in a suspension of 10(6) cells/ml in a buffer containing 5 mM glucose and 5 mg/ml of bovine serum albumin were also exposed to methyl mercuric chloride (4 microM). Almost 50% of the mercurial was taken up by the cells slowly during the incubation period of 240 min. DMSA (1 mM) almost completely blocked the methyl mercury binding by the hepatocytes. 2-Mercaptopropionylglycin (Thiola) or mercaptosuccinic acid (MSA) was almost as effective mercurial scavengers as DMSA in hepatocytes and in red blood cells. Diethyldithiocarbamate (DDC) and dimercaptopropanol (BAL) were considerably less effective than DMSA to inhibit the mercurial binding to hepatocytes. Experiments in vivo have shown that DMSA is a better mercurial chelator than Thiola or MSA, whereas DDC and BAL may both be considered to be inapplicable in methyl mercury poisonings. Our cellular assay provides preliminary information of the efficiency of chelating thiols and may serve as a useful first approximation when planning further experiments.

Comparison of mercury levels in maternal blood, fetal cord blood, and placental tissues

Previous studies have reported that mercury accumulates in cord blood during pregnancy. This study was carried out to determine where in cord blood the mercury accumulates, i.e., in cord erythrocytes, in cord plasma, or in both, and to determine whether the predominant form of mercury which accumulates is methyl or inorganic mercury. From our data it is clear that methyl mercury accumulates in cord erythrocytes: A total of 30% more methyl mercury was found in fetal erythrocytes than in maternal erythrocytes. Also correlation analysis of the methyl mercury levels in maternal and fetal erythrocytes showed a strong correlation (r = 0.87). In regard to inorganic mercury, the highest concentration was found in the placenta, suggesting a barrier role, but a significant correlation (r = 0.62) was also found between the maternal and fetal plasma levels of inorganic mercury. Moreover, the inorganic mercury concentration per gram of plasma was higher in fetal cord plasma than in maternal plasma. Overall, the relative levels of methyl and inorganic mercury reported here varied considerably in materrnal and fetal erythrocytes, plasma, and in the placenta, but all of the levels were low (<6 ng Hg/gm of tissue) and in agreement with Øtotal¿ mercury levels reported by others.

Mechanisms of inhibition of active transport ATPases by mercurials

Inhibition by methylmercury and mercuric chloride of Mg,Ca ATPase and Na,K ATPase activities in human erythrocyte ghosts was correlated with the binding capacity of ghosts for the mercurial. Full inhibition was always reached below saturation of binding capacity, and half-inhibition at levels as low as 10% saturation. Under such conditions, concentrations of free inhibitor were negligibly low, and existing mathematical models of inhibition were not applicable. New inhibitor partition equations were introduced to model the mechanisms of action of mercurials. Up to 7 methylmercury groups were calculated to bind to one Na,K ATPase molecule at non-inhibitory sites, while only one reacted with the inhibitory site. Mg,Ca ATPase showed simple one-hit inhibition (one mercurial per enzyme); further washing of ghosts, however, unmasked a second binding site (cooperative two-hit inhibition). Affinities of mercurials to sites of inhibition were calculated relative to other ligands in erythrocyte membranes: the ratios ranged from 3 : 1 to 50 : 1. The results demonstrated the use of binding capacity assays and inhibitor partition equations to measure and compare the susceptibilities of membrane-bound enzymes to poisoning by mercurials.

Hemolysis and morphological changes in rat erythrocytes with mercurials

Effects of mercurials on rat erythrocytes were studied morphologically using an electron microscope. In the scanning study, the normal biconcave shape of the erythrocytes was changed to rugged surface spherocytes when mercuric chloride was added to the erythrocyte suspension. Methylmercuric chloride produced an irregularity of cell shape with spicules including the final stage of spherocytes. p-Chloromercuribenzoic acid formed crenated cells with protrusion, then spherocytes. By a carbon replica technique, it was revealed that control erythrocytes had a granular surface structure; however the surface of mercuric chloride-treated and methyl-mercuric chloride-treated erythrocytes appeared less granulated. By a negative staining technique, severe damage was observed on the erythrocytes lysed by mercurials. As a decrease in content of reduced glutathione, inhibition of glucose-6-phosphate dehydrogenase activity and formation of methemoglobin in erythrocytes treated with mercurials to induce hemolysis were not observed, it was concluded that the hemolysis induced by mercurials was not due to a disturbance in erythrocyte metabolism but rather to the direct action of mercurials on the cell membrane.

The erythrocyte transport and transfer of methylmercury to the tissues of the rainbow trout (Salmo gairdneri)

Methylmercury (MeHg) was found to be taken up rapidly and almost completely by trout red blood cells (RBC) both in vitro and in vivo. The binding of MeHg within the RBC was freely reversible both in vitro, as shown by the efflux of MeHg from RBCs suspended in protein solutions, and in vivo following intracardial (i.c.) injection of RBC-bound MeHg. Hemoglobin (Hb) appeared to be the main MeHg transport protein in trout blood since it bound 90% of whole blood Hg following an intragastric dose of Me203HgCl. MeHg, injected i.c. as MeHgS-cysteine, was found to be present in blood bound almost completely to hemoglobin 10 days post-injection. This suggests an ability of hemoglobin to compete for and bind MeHg bound to other sulfhydryl (-SH) compounds. The number of reactive -SH groups per molecule of trout Hb was determined to be 4 by amperometric titration with MeHgCl. The concentration of Hb reactive -SH groups in the trout RBC was calculated to be at least 20 mM. This accounts for the high affinity of the RBC for MeHg.